InnovationRx is your weekly digest of healthcare information. To get it in your inbox, subscribe right here.
AI for drug discovery was a high space of funding.
getty
Venture capital investments in biopharma have been down in 2023, in response to a new report from PitchBook, which discovered there was $29.9 billion invested within the sector, in comparison with $36.7 billion in 2022. The report sums up a number of the cause for this as a shift in strategic pondering as traders are “supporting fewer corporations however with important improvement progress.” This bodes properly for established biotechs in search of later-stage funding however could spark considerations for these whose tech is extra experimental. Biotech corporations most likely must be planning for longer runways after getting funding, too, because the report notes “an elevated median interval” between rounds.
Two large areas of curiosity to traders in 2023 are not any large shock: AI for drug discovery and weight problems medication, which have attracted funding curiosity due to large exits in addition to multi-billion greenback analysis partnerships with large pharma corporations. However the report notes there are additionally three rising therapeutic areas which are additionally attracting elevated consideration: molecular glues, that are getting used to open up protein degradation as a remedies possibility for cancers and different ailments; epigenetic modifying, which provides potential efficacy for genetic issues with out a number of the security challenges of standard gene remedy; and macrocyclic peptides, small proteins that doubtlessly supply the advantages of each biologics and small molecules with out their drawbacks.
Meet CHAI: The Nonprofit Supergroup Wrangling Well being AI’s Wild West
Brian Anderson, govt director, Coalition for Well being AI.
Coalition for Well being AI
The Coalition for Well being AI, which has over 1,300 members, is seeking to develop requirements, validation labs and a nationwide registry of well being AI instruments. Board members embody representatives from Microsoft, FDA, ONC, Mayo Clinic, Bessemer Enterprise Companions, Johns Hopkins and others.
Learn extra right here.
Pipeline & Deal Updates
Over-The-Counter: The FDA cleared Dexcom’s Stelo as the primary steady glucose monitor to be bought over-the-counter for individuals “who wish to higher perceive how eating regimen and train could influence blood sugar ranges.” The gadget information readings each quarter-hour and customers can put on the sensor for as much as 15 days, however the company warns that it shouldn’t be used to make medical choices with out consulting a healthcare supplier.
Autoimmune Remedies: Alumis, which is growing medication aimed toward treating immunological ailments like psoriasis and lupus, introduced it has raised a $259 million sequence C spherical co-led by Foresite Capital Samsara BioCapital and venBio Companions. The spherical is aimed toward supporting part 2 and three medical trials for its lead drug candidate.
M&A: Phage remedy biotech BiomX introduced that it’s entered right into a merger agreement with Adaptive Phage Therapeutics. The brand new non-public firm can be owned 55% by BiomX shareholders and 45% by APT shareholders and consists of $50 million in gross proceeds to BiomX.
Digital Prognosis: BrainCheck, which has developed a digital software for cognitive evaluation, introduced it has raised a $15 million financing round to speed up the commercialization of its software.
Bone Most cancers: Medtronic introduced that it has received FDA clearance for its OsteoCool 2.0 gadget, which is used to carry out tumor ablations for sufferers with bone most cancers.
Precision Oncology: FogPharma, which is growing a platform class of therapeutics aimed toward hard-to-target cancers, introduced it has raised a $145 million series E round led by Nextech Make investments. The brand new funding is geared in direction of the medical improvement of its drug candidate FOG-001, which is aimed toward colorectal most cancers.
TikTokers Are Stealing Medical doctors And Nurses’ Images To Peddle Capsules And Powders
ILLUSTRATION BY ANGELICA ALZONA FOR FORBES
Healthcare staff’ names and selfies are getting used – with out their consent or data – to promote unproven medical remedies to the app’s monumental international viewers. And within the Wild West of loosely regulated dietary supplements, many manufacturers are profiting.
Learn extra right here.
Different Healthcare Information
Walgreens Boots Alliance CEO Tim Wentworth mentioned the corporate gained’t promote its fast-growing Shields specialty pharmacy, including it’s a key a part of the corporate’s progress technique.
Opill, the primary over-the-counter contraception permitted to be used within the U.S., can be available in shops later this month.
CVS and Walgreens will start promoting the abortion tablet mifepristone at pharmacies throughout choose states within the coming weeks.
A research printed in The Lancet estimates over 1 billion individuals now have weight problems worldwide.
CVS Well being is ramping up its inexpensive housing push and can spend round $35 million for 2 new housing developments in Hawaii in areas broken by the Maui wildfires final yr.
Alabama legislators superior payments defending in vitro fertilization suppliers from civil and legal legal responsibility, following a court docket ruling that frozen embryos are youngsters.
The CDC is not recommending individuals with Covid-19 isolate for 5 days.
Throughout Forbes
This Invoice Gates-Backed Startup Is Attempting To Repair Metal’s Horrible Environmental Impression
The Highest-Paid Actors Of 2023
This Billionaire Investor Takes Recommendation From Usher
What Else We’re Studying
How the U.S. is sabotaging its best tools to prevent deaths in the opioid epidemic (STAT)
Charges for emails with doctors and other healthcare providers (KFF)
Millions of research papers at risk of disappearing from the Internet (Nature)